Modis Therapeutics competitorsClear all
Modis Therapeutics's top competitors include Bluebird Bio, Ultragenyx Pharmaceutical and Polyplus-transfection.
 Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases. |  Polyplus-transfection Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics. | |||
Founding Date | Founding Date 2016 | Founding Date 1992 | Founding Date 2010 | Founding Date 2002 |
Type | Type Subsidiary | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Oakland, US HQ | Locations Novato, US HQ | Locations Illkirch-Graffenstaden, FR HQ New York, US | |
Employees | Employees 109% decrease | Employees 1,2134% increase | Employees 74021% increase | Employees 1142% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 290.2 m | Valuation ($) 4.1 b | Valuation ($) N/A |
Twitter followers | Twitter followers N/A | Twitter followers 10.1 k | Twitter followers N/A | Twitter followers 250 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 17 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 7 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 7.8 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 0.6 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 71.43% |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank 513212 | Alexa Website Rank N/A | Alexa Website Rank 656900 |
Employee Rating | Employee Rating N/A | Employee Rating 3.6 | Employee Rating 4.4 | Employee Rating 4.8 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $250.7m (FY, 2020) | Revenue (est.) $271m (FY, 2020) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($618.7m) (FY, 2020) | Net income ($186.6m) (FY, 2020) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 30m | Total funding raised $ 409m | Total funding raised $ 200.1m | Total funding raised $ 3.2m |
For sources of this data, please see the company profile
View company profiles
Bluebird Bio
HQ
Cambridge, US
Employees
1,213↑ 4% increase
Bluebird Bio is a developer of gene therapies for severe genetic diseases and cancer.
View companyUltragenyx Pharmaceutical
HQ
Novato, US
Employees
740↑ 21% increase
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
View companyPolyplus-transfection
HQ
Illkirch-Graffenstaden, FR
Employees
114↑ 2% increase
Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
View company